Structural Connectivity in Currently Medicated Treatment-Resistant vs. Treatment-Responsive Depression: A Diffusion Tensor Imaging Study

被引：0
|
作者：
Conroy, Susan [1 ]
Elsaid, Nahla [1 ]
Wen, Qiuting [1 ]
Kelley, Mary [2 ]
Ford, James [3 ]
Wu, Yu-Chien [1 ]
Holtzheimer, Paul [3 ]
机构：
[1] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
[2] Emory Univ, Sch Med, Atlanta, GA 30322 USA
[3] Geisel Sch Med Dartmouth, Hanover, NH USA
来源：
BIOLOGICAL PSYCHIATRY | 2020年 / 87卷 / 09期
关键词：
Treatment-Resistant Depression; Diffusion Tensor Imaging (DTI); Antidepressant Medication;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [11] Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis
    Millgate, Edward
    Hide, Olga
    Lawrie, Stephen M.
    Murray, Robin M.
    MacCabe, James H.
    Kravariti, Eugenia
    PSYCHOLOGICAL MEDICINE, 2022, 52 (01) : 1 - 13
  • [12] MAGNETIC-RESONANCE-IMAGING AND SINGLE-PHOTON EMISSION TOMOGRAPHY IN TREATMENT-RESPONSIVE AND TREATMENT-RESISTANT SCHIZOPHRENIA
    LAWRIE, SM
    INGLE, GT
    SANTOSH, CG
    ROGERS, AC
    RIMMINGTON, JE
    NAIDU, KP
    BEST, JJK
    OCARROLL, RE
    GOODWIN, GM
    EBMEIER, KP
    JOHNSTONE, EC
    BRITISH JOURNAL OF PSYCHIATRY, 1995, 167 : 202 - 210
  • [13] Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
    Gillespie, Amy L.
    Samanaite, Ruta
    Mill, Jonathan
    Egerton, Alice
    MacCabe, James H.
    BMC PSYCHIATRY, 2017, 17
  • [14] Is treatment-resistant schizophrenia categorically distinct from treatment-responsive schizophrenia? a systematic review
    Amy L. Gillespie
    Ruta Samanaite
    Jonathan Mill
    Alice Egerton
    James H. MacCabe
    BMC Psychiatry, 17
  • [15] Dopamine receptors in prefrontal cortex mediate effects of venlafaxine, but not DBS, in animal models of treatment-responsive and treatment-resistant depression
    Gruca, P.
    Papp, M.
    Lason, M.
    Niemczyk, M.
    Litwa, E.
    Willner, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S37 - S37
  • [16] Comparative analysis of the risk of severe bacterial infection and septicemia in adolescents and young adults with treatment-resistant depression and treatment-responsive depression - a nationwide cohort study in Taiwan
    Li, Jia-Ru
    Kao, Yu-Chen
    Tsai, Shih-Jen
    Bai, Ya-Mei
    Su, Tung-Ping
    Chen, Tzeng-Ji
    Liang, Chih-Sung
    Chen, Mu-Hong
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2025,
  • [17] Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression
    Rivas-Grajales, Ana Maria
    Salas, Ramiro
    Robinson, Meghan E.
    Qi, Karen
    Murrough, James W.
    Mathew, Sanjay J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (05): : 383 - 391
  • [18] Characterization of brain functional connectivity in treatment-resistant depression
    Amiri, Saba
    Arbabi, Mohammad
    Kazemi, Kamran
    Parvaresh-Rizi, Mansour
    Mirbagheri, Mehdi M.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 111
  • [19] Olanzapine vs. chlorpromazine in treatment-resistant schizophrenia
    Conley, RR
    Tamminga, CA
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 471 - 471
  • [20] Olanzapine vs. chlorpromazine in treatment-resistant schizophrenia
    Conley, RR
    Tamminga, CA
    Beasley, C
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 246 - 246
12345